Blood Sample Collection in Subjects With Pulmonary Nodules or CT Suspicion of Lung Cancer or Pathologically Diagnosed Lung Cancer
NCT ID: NCT03633006
Last Updated: 2021-02-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
3298 participants
OBSERVATIONAL
2016-04-11
2020-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Blood Sample Collection in Subjects Participating in a Lung Cancer Screening Program
NCT03628638
Biomarkers for Diagnosis of Lung Cancer
NCT02050100
Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, >6 to <30 mm in Diameter, Determined by LDCT.
NCT07168993
Monitoring the Changes of Tumor-related Biomarkers Before and After Pulmonary Nodule Biopsy.
NCT03397355
Prospective Collection of Whole Blood From Active Non-Small Cell Lung Cancer Patients for Supplemental Research
NCT05669105
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pulmonary Nodules
Subject with pulmonary nodules will be enrolled, provide a blood sample and may be followed up to 2 years for nodule resolution.
A second blood draw will be collected at 12 months.
Blood Sample Collection
Subjects participating in the study will have blood drawn at enrollment. Additional blood samples may be collected at 12 months from enrollment.
CT Suspicion of Cancer
Subject with suspicion of lung cancer will provide a blood sample.
Diagnostic information will be collected to confirm the final diagnosis.
Blood Sample Collection
Subjects participating in the study will have blood drawn at enrollment. Additional blood samples may be collected at 12 months from enrollment if lung cancer has not been confirmed.
Pathologically Confirmed Cancer
Subject has pathologically confirmed lung cancer and is treatment naïve.
Subject will be enrolled and provide a blood sample.
Blood Sample Collection
Subjects participating in the study will have blood drawn at enrollment.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blood Sample Collection
Subjects participating in the study will have blood drawn at enrollment. Additional blood samples may be collected at 12 months from enrollment.
Blood Sample Collection
Subjects participating in the study will have blood drawn at enrollment. Additional blood samples may be collected at 12 months from enrollment if lung cancer has not been confirmed.
Blood Sample Collection
Subjects participating in the study will have blood drawn at enrollment.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Subject is male or female, 35 years of age or older.
2. Subject has at least one CT confirmed 6-30 mm nodule.
3. Subject understands the study procedures and is able to provide informed consent to participate in the study and authorization for release of relevant protected health information to the study Investigator.
Suspicion of Cancer Subjects:
4. Subject has CT suspicion of lung cancer and is scheduled for biopsy or other diagnostic procedure.
Pathologically Confirmed Cancer Subjects:
4\. Subject has pathologically confirmed lung cancer and is treatment naïve.
Pulmonary Nodule Subjects:
4\. Subject has a recent (within 90 days of enrollment) CT radiological diagnosis of pulmonary nodule(s) without a scheduled biopsy/diagnostic procedure (other than CT or PET/CT).
Exclusion Criteria
1. CT with IV contrast within 1 day \[or 24 hours\] of blood collection.
2. Prior history of cancer within the past 5 years except for non-melanoma skin cancer. For subjects with suspicion of lung cancer who may have a concurrent work-up for another primary cancer, the non-lung cancer primary must be ruled out prior to enrollment.
3. Prior removal of the lung, excluding percutaneous lung biopsy.
4. Treatment (e.g., surgical resection, radiofrequency ablation) for pulmonary nodules prior to blood sample collection for this trial.
5. Individual has a condition the Investigator believes would interfere with his or her ability to provide informed consent, comply with the study protocol, which might confound the interpretation of the study results or put the person at undue risk.
Pathologically Confirmed Cancer Subjects:
6. Biopsy within 7 days prior to blood collection.
7. Unresolved bleeding as a result of biopsy at the time of enrollment.
35 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Exact Sciences Corporation
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Laura Strong
Role: STUDY_DIRECTOR
Exact Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Achieve Clinical Research
Birmingham, Alabama, United States
Phoenix Medical Group
Peoria, Arizona, United States
Newport NativeMD
Newport Beach, California, United States
Palmtree Clinical Research, Inc
Palm Springs, California, United States
Palo Alto Veterans Health Care
Palo Alto, California, United States
Premier Medical Group
Upland, California, United States
American Research Institute, Inc
Cutler Bay, Florida, United States
International Research Partners, LLC
Doral, Florida, United States
Jupiter Medical Center
Jupiter, Florida, United States
Pulmonary Disease Specialists
Kissimmee, Florida, United States
Medical Research of Central Florida, LLC
Leesburg, Florida, United States
Future Clinical Research
Miami, Florida, United States
University of Miami Miller School of Medicine
Miami, Florida, United States
Orcinova AMS Research
Miami, Florida, United States
Sunrise Research Institute, Inc
Miami, Florida, United States
American Research Medical Group
Miami, Florida, United States
Health and Life Research Institute, LLC
Miami, Florida, United States
Care Research Center
Miami, Florida, United States
Clinical Trials of Florida, LLC
Miami, Florida, United States
AMPM research Clinic
Miami Gardens, Florida, United States
Sarasota Memorial Hospital Clinical Research Center
Sarasota, Florida, United States
Coastal Pulmonary and Critical Care, PLC
St. Petersburg, Florida, United States
Pasadena Center for Medical Research, Inc
St. Petersburg, Florida, United States
Florida Pulmonary Research Institute, LLC
Winter Park, Florida, United States
Pulmonary Care Research Group, PA
Winter Park, Florida, United States
Piedmont Healthcare, Inc.
Atlanta, Georgia, United States
Gwinnett Research institute, LLC
Buford, Georgia, United States
Columbus Regional Research Institute
Columbus, Georgia, United States
Gwinnett Biomedical Research
Lawrenceville, Georgia, United States
DC Research Work
Marietta, Georgia, United States
Southeast Lung Associates Research
Rincon, Georgia, United States
Saltzer Medical Group
Nampa, Idaho, United States
PMG Research of Christie Clinic
Champaign, Illinois, United States
Medical and Procedural Specialists of Illinois, LLC
Chicago, Illinois, United States
Loyola University Chicago
Maywood, Illinois, United States
Community Hospital of Anderson and Madison County, Inc.
Anderson, Indiana, United States
Heartland Research Associates, LLC-An AMR Company
Augusta, Kansas, United States
Johns Hopkins University School of Medicine
Baltimore, Maryland, United States
Meritus Center for Clinical Research
Hagerstown, Maryland, United States
MedStar Shah Medical Group
Hollywood, Maryland, United States
Lahey Clinic, Inc
Burlington, Massachusetts, United States
Newton-Wellesley Hospital
Newton, Massachusetts, United States
Baystate Medical Center
Springfield, Massachusetts, United States
Somnos Laboratories
Lincoln, Nebraska, United States
Creighton University
Omaha, Nebraska, United States
Virtua Health, Inc
Marlton, New Jersey, United States
Pulmonary Ultimate Research Experience, LLC (PURE, LLC)
Toms River, New Jersey, United States
Albany Medical College MC-91
Albany, New York, United States
Jamaica Hospital Medical Center
Jamaica, New York, United States
Northwell Health
New Hyde Park, New York, United States
American Health Research, LLC
Charlotte, North Carolina, United States
Clinical Research of Gastonia
Gastonia, North Carolina, United States
Gastonia Pharmaceutical Research
Gastonia, North Carolina, United States
Pulmonix, LLC
Greensboro, North Carolina, United States
Hickory Research Center DBA Research Carolina of Hickory
Hickory, North Carolina, United States
Coastal Carolina Health Care
New Bern, North Carolina, United States
PMG Research of Rocky Mount, LLC
Rocky Mount, North Carolina, United States
PMG Research of Wilmington, LLC
Wilmington, North Carolina, United States
Cleveland Clinic
Cleveland, Ohio, United States
Clinical Trial Developers, Inc.
Milford, Ohio, United States
OK Clinical Research, LLC
Edmond, Oklahoma, United States
The Oregon Clinic, PC
Portland, Oregon, United States
Chest Diseases of Northwestern PA
Erie, Pennsylvania, United States
Research Protocol Management Specialists
Pittsburgh, Pennsylvania, United States
Safe Harbor Clinical Research
East Providence, Rhode Island, United States
Anderson Pharmaceutical Research, LLC
Anderson, South Carolina, United States
Charletson Research Institute
Charleston, South Carolina, United States
The Medical University of South Carolina
Charleston, South Carolina, United States
VitaLink Research--Gaffney (Gaffney Pharmaceutical Research, LLC)
Gaffney, South Carolina, United States
Clinical Research of Charleston
Mt. Pleasant, South Carolina, United States
Clinical Research of Rock HIll
Rock Hill, South Carolina, United States
VitaLink Research-Rock Hill
Rock Hill, South Carolina, United States
South Carolina Pharmaceutical Research, LLC
Spartanburg, South Carolina, United States
Union Pharmaceutical Research
Union, South Carolina, United States
Houston Pulmonary Sleep and Allergy Associates
Cypress, Texas, United States
University of Texas Medical Branch
Galveston, Texas, United States
Envision Cancer Care, LLC
Laredo, Texas, United States
Renovatio Clinical Consultants, LLC
The Woodlands, Texas, United States
Renovatio Clinical
The Woodlands, Texas, United States
Pulmonary Associates of Richmond
Richmond, Virginia, United States
Overlake Hospital Medical Center
Bellevue, Washington, United States
University of Wisconsin School of Medicine and Public Health
Madison, Wisconsin, United States
William S. Middleton Memorial Veterans Hospital
Madison, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2016-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.